MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

Meeting: 2018 International Congress

Abstract Number: 1075

Keywords: Eye movement, Restless legs syndrome(RLS): Clinical features

Session Information

Date: Sunday, October 7, 2018

Session Title: Restless Legs Syndrome and Other Sleep Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To assess the ability to inhibit eye movements towards a target by analysing antisaccades using an eye tracker.

Background: Restless legs syndrome (RLS) is a common neurological disease, affecting up to 10% of the population. Dopaminergic drugs, especially dopamine agonists, are commonly used to alleviate symptoms. However, these drugs may induce unwanted side effects such as augmentation or impulse control disorders in a subgroup of patients.

Methods: In total, we included 17 patients with idiopathic RLS diagnosed according to the International Restless Legs Syndrome Study Group criteria from our out-patient clinic. Eleven patients had a history of augmentation, 6 patients had neither augmentation nor impulse control disorders. Data acquisition was done by using a Tobii eye tracking system and the Pro Lab software.

Results: We first examined the mean reaction time using a Kolmogorov-Smirnov test and a t-test for independent samples. There was no difference in mean reaction time for patients with augmentation (282.75 ms, SD=88.07) and for patients without augmentation (298.24 ms, SD=58.03), (p=0.706). Secondly, we assessed error rates in the antisaccade task. The error rate in patients with augmentation was 40.9% (SD=28.3) compared to 10.5% (SD=11.5) in patients without augmentation, showing a significant group difference (p=0.007).

Conclusions: These preliminary data from an ongoing study suggest that patients with augmentation have difficulties suppressing overt attention towards the target. These frequent antisaccade errors in the augmentation group are typical of response initiation impulsivity. Furthermore, these interim results are consistent with previous reports linking augmentation and enhanced impulsivity and we are continuing to enrol patients in this study to solidify our data in a larger sample.

To cite this abstract in AMA style:

P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian. Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/eye-tracking-in-patients-with-restless-legs-syndrome-with-and-without-augmentation-interim-results-of-an-ongoing-study/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/eye-tracking-in-patients-with-restless-legs-syndrome-with-and-without-augmentation-interim-results-of-an-ongoing-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley